| Company Name: | WebMD Health Corporation Class A | | Ticker Symbol: | WBMD | | | WWW Address: | www.webmd.com | | CEO: | Wayne T. Gattinella | | No. of Employees: | 1,300 | | Common Issue Type: | CS | | Business Description: | The Company provides health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals and health-focused publications.
|
| | | Industry Information: | INTERNET - Internet Information Providers [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 36.37 |  0.12 | 36.03 | 37.0 | 36.13 | 36.39 | 36.12 | 264698 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 2,124.0 | 58.4 | 1.21 | 0.45 | 0.00 | 42.3 | 0.0 | 36.75 - 18.00 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 36.37 | $ | | PE Ratio - LTM | 42.3 | |
| Market Capitalisation | 376.0 | mil |
| Latest Shares Outstanding | 58.4 | mil |
| Earnings pS (EPS) | 0.45 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 294,444 | $ |
| Effective Tax Rate | 10.1 | % |
| Float | 57.4 | mil |
| Float as % of Shares Outstanding | 98.2 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 41.60 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 62.0 | % |
| EBITDA Margin | 20.4 | % |
| Pre-Tax Profit Margin | 14.1 | % |
| Assets Turnover | 0.5 | % |
| Return on Assets (ROA) | 6.4 | % |
| Return on Equity (ROE) | 7.6 | % |
| Return on Capital Invested (ROCI) | 7.6 | % |
| Current Ratio | 3.2 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 4.36 | $ |
| Cash pS | 4.71 | $ |
| Book-Value pS | 11.46 | $ |
| Tangible Book-Value pS | 7.52 | $ |
| Cash Flow pS | 1.34 | $ |
| Free Cash Flow pS | 1.49 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.17 | |
| Price/Tangible Book Ratio | 4.84 | |
| Price/Cash Flow | 27.1 | |
| Price/Free Cash Flow | 24.4 | |
| P/E as % of Industry Group | 33.0 | % |
| P/E as % of Sector Segment | 43.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.3 | 99 | 2,151 | 2,097 |
| 4 Weeks | 36.75 | 33.25 | 34.06 | 6.8 | 100 | 2,987 | 47,790 |
| 13 Weeks | 36.75 | 31.00 | 32.83 | 10.8 | 103 | 1,401 | 84,031 |
| 26 Weeks | 36.75 | 25.61 | 27.16 | 33.9 | 111 | 996 | 123,546 |
| 52 Weeks | 36.75 | 18.00 | 19.18 | 89.6 | 154 | 1,160 | 287,793 |
| YTD | 36.75 | 19.37 | - | 54.2 | 126 | 1,133 | 255,991 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 36.30 | 36.30 | 34.24 | 31.45 | 29.04 | 1.21 | 1.19 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 27.61 | 95.8 | 17.98 |
| Income | 0.00 | 0.0 | 105.70 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 6.61 | NA | -40.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 131.72 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 10.8 | 11.1 | 15.3 |
| Earnings % | 0.0 | 18.8 | -59.5 |
| EPS % | 0.0 | 16.7 | -59.1 |
| EPS $ | 0.41 | 0.03 | -0.65 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 24.74 |
| Current Ratio | 2.7 |
| Quick Ratio (Acid Test) | 2.5 |
| Liquidity Ratio (Cash) | 1.71 |
| Receivables Turnover | 4.2 |
| Average Collection Period | 86 |
| Working Capital/Equity | 29.5 |
| Working Capital pS | 3.20 |
| Cash-Flow pS | 0.94 |
| Free Cash-Flow pS | 1.32 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.85 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 16.0 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 1.3 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.36 |
| Tobin's Q Ratio | 0.50 |
| Current P/E Ratio - LTM | 42.30 |
| Enterprise Value (EV)/EBITDA | 3.91 |
| Enterprise Value (EV)/Free Cash Flow | 7.36 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 4.84 |
| Price/Book Ratio - LTM | 3.17 |
| Price/Cash Flow Ratio | 27.1 |
| Price/Free Cash Flow Ratio - LTM | 24.4 |
| Price/Sales Ratio | 5.16 |
| P/E Ratio (1 month ago) - LTM | 39.9 |
| P/E Ratio (26 weeks ago) - LTM | 30.2 |
| P/E Ratio (52 weeks ago) - LTM | 27.4 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 33.0 |
| P/E as % of Sector Segment | 43.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 36.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.93 |
| Tangible Book Value pS - LTM | 7.52 |
| Book Value pS - LTM | 11.46 |
| Capital Invested pS | 10.84 |
| Cash pS - LTM | 4.71 |
| Cash Flow pS - LTM | 1.34 |
| Free Cash Flow pS - LTM | 1.49 |
| Earnings pS (EPS) | 0.45 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 20.12 |
| Free Cash Flow Margin 5YEAR AVG | -6.18 |
| Net Profit Margin | 7.0 |
| Net Profit Margin - 5YEAR AVRG. | 8.8 |
| Equity Productivity | 0.60 |
| Return on Equity (ROE) | 4.2 |
| Return on Equity (ROE) - 5YEAR AVRG. | 5.2 |
| Capital Invested Productivity | 0.60 |
| Return on Capital Invested (ROCI) | 4.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 5.2 |
| Assets Productivity | 0.50 |
| Return on Assets (ROA) | 3.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | 4.3 |
| Gross Profit Margin | 62.0 |
| Gross Profit Margin - 5YEAR AVRG. | 61.9 |
| EBITDA Margin - LTM | 20.4 |
| EBIT Margin - LTM | 14.1 |
| Pre-Tax Profit Margin | 7.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 7.6 |
| Effective Tax Rate | 10.1 |
| Effective Tax Rate - 5YEAR AVRG. | 2.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 89 |
| Revenue per Employee | 294,444 |
| Net Income per Employee | 20,540 |
| Average Collection Period | 89 |
| Receivables Turnover | 4.2 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 0.11 |
| Assets/Revenue | 2.00 |
| Net Working Capital Turnover | 2.05 |
| Fixed Assets Turnover | 0.84 |
| Total Assets Turnover | 0.5 |
| Revenue per $ Cash | 2.00 |
| Revenue per $ Plant | 7.05 |
| Revenue per $ Common Equity | 0.60 |
| Revenue per $ Capital Invested | 0.60 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 43.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 47.2 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |